Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP19A1 | P11511 | 2/20 | 0.41 |
| ▸ | MAPT | P10636 | 3/20 | 0.35 |
| ▸ | RAB9A | P51151 | 2/20 | 0.35 |
| ▸ | NPC1 | O15118 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | EPHX1 | P07099 | 2/20 | 0.32 |
| ▸ | MEN1 | O00255 | 2/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.32 |
| ▸ | HCRTR2 | O43614 | 1/20 | 0.32 |
| ▸ | FABP7 | O15540 | 1/20 | 0.31 |
| ▸ | FABP5 | Q01469 | 1/20 | 0.31 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.31 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.31 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.31 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
| ▸ | SERPINE1 | P05121 | 1/20 | 0.31 |
| ▸ | POLB | P06746 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20152479 | 1.00 | CYP19A1 (0.41) | CYP19A1MAPTRAB9ANPC1ALDH1A1 | |
| SCHEMBL20152476 | 1.00 | CYP19A1 (0.41) | CYP19A1MAPTRAB9ANPC1ALDH1A1 | |
| SCHEMBL20275995 | 1.00 | CYP19A1 (0.41) | CYP19A1MAPTRAB9ANPC1ALDH1A1 | |
| SCHEMBL20276012 | 1.00 | CYP19A1 (0.41) | CYP19A1MAPTRAB9ANPC1ALDH1A1 | |
| SCHEMBL20152474 | 1.00 | CYP19A1 (0.41) | CYP19A1MAPTRAB9ANPC1ALDH1A1 | |
| SCHEMBL170528 | 0.94 | CYP19A1 (0.38) | CYP19A1MAPTRAB9ANPC1ALDH1A1 | |
| SCHEMBL14274401 | 0.94 | CYP19A1 (0.38) | CYP19A1MAPTRAB9ANPC1ALDH1A1 | |
| SCHEMBL20152489 | 0.94 | CYP19A1 (0.38) | CYP19A1MAPTRAB9ANPC1ALDH1A1 | |
| SCHEMBL14465468 | 0.94 | CYP19A1 (0.38) | CYP19A1MAPTRAB9ANPC1ALDH1A1 | |
| SCHEMBL13074339 | 0.94 | CYP19A1 (0.38) | CYP19A1MAPTRAB9ANPC1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 39 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023199989-A1 | LIGHT DIMMING DEVICE | 凸版印刷株式会社 | 2023-10-19 | — | — | WO | disclosed |
| US-20230231270-A1 | Separator and Application Thereof | MICROCOSM TECHNOLOGY CO., LTD. (TW) | 2023-07-20 | — | — | US | disclosed |
| EP-4213290-A2 | SEPARATOR AND APPLICATION THEREOF | Microcosm Technology Co., Ltd. (TW) | 2023-07-19 | — | — | EP | disclosed |
| US-20180171229-A1 | LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE | DIC CORPORATION (JP) | 2018-06-21 | — | — | US | disclosed |
| US-20180171234-A1 | LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE USING THE SAME | DIC CORPORATION (JP) | 2018-06-21 | — | — | US | disclosed |
| US-20180134961-A1 | LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE USING THE SAME | DIC CORPORATION (JP) | 2018-05-17 | — | — | US | disclosed |
| EP-1618101-B1 | BENZOCHROMENE DERIVATIVES | MERCK PATENT GMBH (DE) | 2017-12-20 | — | — | EP | disclosed |
| EP-3130650-A1 | LIQUID-CRYSTALLINE MEDIUM | Merck Patent GmbH (DE) | 2017-02-15 | — | — | EP | disclosed |
| WO-2017008884-A1 | METHOD OF REDUCING ODF MURA IN POLYMER STABILISED LIQUID CRYSTAL DISPLAYS | MERCK PATENT GMBH (DE) | 2017-01-19 | — | — | WO | disclosed |
| US-9238775-B2 | Switch element comprising a liquid-crystalline medium | MERCK PATENT GMBH (DE) | 2016-01-19 | — | — | US | disclosed |
| US-7335404-B2 | Liquid crystal composition for use in bistable liquid crystal devices | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 2008-02-26 | — | — | US | disclosed |
| US-7326447-B2 | Benzochromene derivatives | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 2008-02-05 | — | — | US | disclosed |
| US-20080020148-A1 | Chromane Derivatives Method for Production and the Use Thereof | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 2008-01-24 | — | — | US | disclosed |
| US-7314653-B2 | Liquid-crystal medium and electro-optical display containing same | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 2008-01-01 | — | — | US | disclosed |
| US-7294368-B2 | Liquid crystal composition for use in bistable liquid crystal devices | MERCK PATENT GMBH (DE) | 2007-11-13 | — | — | US | disclosed |
| US-7270856-B2 | Cyclobutane derivatives | MERCK PATENT GMBH (DE) | 2007-09-18 | — | — | US | disclosed |
| US-7258903-B2 | Fast switching liquid crystal compositions for use in bistable liquid crystal devices | MERCK PATENT GMBH (DE) | 2007-08-21 | — | — | US | disclosed |
| US-20070176144-A1 | Liquid crystal composition for bistable liquid crystal devices | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 2007-08-02 | — | — | US | disclosed |
| US-20070080325-A1 | Liquid crystal composition for use in bistable liquid crystal devices | MERCK PATENT GMBH (DE) | 2007-04-12 | — | — | US | disclosed |
| EP-1567613-B1 | CYCLOBUTANE DERIVATIVES | MERCK PATENT GMBH (DE) | 2007-03-07 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080020148-A1 | Chromane Derivatives Method for Production and the Use Thereof | C1S, CHRM1, C1R | CYP19A1 142/4885MAPT 3652/4885RAB9A 2453/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.